IRIDEX (IRIX) Proxy Filing summary

Executive summary

• The annual meeting is scheduled for June 11, 2025, at the company’s headquarters in Mountain View, CA.

• Key proposals include director elections, auditor ratification, approval of significant share issuances, charter amendments, equity plan amendments, and advisory votes on executive compensation.

• A major transaction with Novel Inspiration International Co., Ltd. involves the issuance of Series B Preferred Stock and convertible notes, potentially increasing Novel’s ownership to over 19.99% pending shareholder approval.

• The board recommends voting in favor of all proposals.

Voting matters and shareholder proposals

• Proposals include electing five directors, ratifying BPM LLP as auditor, approving the issuance of Novel Shares, amending the certificate of incorporation, amending the 2008 Equity Incentive Plan, advisory votes on executive compensation and its frequency, and potential adjournment.

• Shareholder approval is sought for the issuance of up to 11,857,142 shares to Novel, exceeding 19.99% of outstanding shares, as required by Nasdaq rules.

• Amendments to the charter would increase authorized common stock from 30M to 100M shares and modernize governance provisions.

• The equity plan amendment seeks to add 1M shares and extend the plan to 2035.

• Advisory votes include say-on-pay and annual frequency for future say-on-pay votes.

Board of directors and corporate governance

• The board consists of five members, with four deemed independent under Nasdaq standards.

• Committees include Audit, Compensation, Nominating and Governance, and a newly formed Strategy and Budget Committee.

• The board encourages diversity in skills and background and has formal policies for director nominations and communications.

• Corporate governance guidelines and a code of business conduct and ethics are in place.